[D9k]Hymenochirin-1Pa

General Information


DRACP ID  DRACP00513

Peptide Name   [D9k]Hymenochirin-1Pa

Sequence  LKLSPKTKkTLKKVLKGAIKGAIAIASMA

Sequence Length  29

UniProt ID  Not available

PubChem CID  Not available

Origin  skin secretions of the frog Pseudhymenochirus merlini (Pipidae)

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma LC50=2.5±0.3 μM CellTiter-Glo Luminescent Cell Viability assay  24h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma LC50=5.4±0.4 μM CellTiter-Glo Luminescent Cell Viability assay  24h 1
HT-29 Colon adenocarcinoma Carcinoma LC50=6.3±1.9 μM CellTiter-Glo Luminescent Cell Viability assay  24h 1

Hemolytic Activity  Human red blood cells (RBC): LC50>400 μM

Normal (non-cancerous) Cytotoxicity  HUVEC: LC50=9.3±0.3 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  k=D-Lys

Chiral  Mix



Physicochemical Information


Formula  C132H241N35O32S

Absent amino acids  CDEFHNQRWY

Common amino acids  K

Mass  336228

Pl  11.58

Basic residues  7

Acidic residues  0

Hydrophobic residues  13

Net charge  7

Boman Index  97

Hydrophobicity  38.28

Aliphatic Index  121.38

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25241629

Title  Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin-1Pa

Doi 10.1016/j.peptides.2014.08.017

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.